FI107696B - Lipidipartikkelinmuodostusmatriisi ja menetelmä sen valmistamiseksi - Google Patents

Lipidipartikkelinmuodostusmatriisi ja menetelmä sen valmistamiseksi Download PDF

Info

Publication number
FI107696B
FI107696B FI922452A FI922452A FI107696B FI 107696 B FI107696 B FI 107696B FI 922452 A FI922452 A FI 922452A FI 922452 A FI922452 A FI 922452A FI 107696 B FI107696 B FI 107696B
Authority
FI
Finland
Prior art keywords
lipid
polar
particle formation
formation matrix
matrix according
Prior art date
Application number
FI922452A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI922452A0 (fi
FI922452A (fi
Inventor
Bengt Hersloef
Martin Nicklasson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of FI922452A0 publication Critical patent/FI922452A0/fi
Publication of FI922452A publication Critical patent/FI922452A/fi
Application granted granted Critical
Publication of FI107696B publication Critical patent/FI107696B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Fertilizers (AREA)
FI922452A 1990-09-28 1992-05-27 Lipidipartikkelinmuodostusmatriisi ja menetelmä sen valmistamiseksi FI107696B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9003100 1990-09-28
SE9003100A SE9003100D0 (sv) 1990-09-28 1990-09-28 Lipid formulation system
SE9100639 1991-09-24
PCT/SE1991/000639 WO1992005771A1 (en) 1990-09-28 1991-09-24 Lipid formulation system

Publications (3)

Publication Number Publication Date
FI922452A0 FI922452A0 (fi) 1992-05-27
FI922452A FI922452A (fi) 1992-05-27
FI107696B true FI107696B (fi) 2001-09-28

Family

ID=20380490

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922452A FI107696B (fi) 1990-09-28 1992-05-27 Lipidipartikkelinmuodostusmatriisi ja menetelmä sen valmistamiseksi

Country Status (15)

Country Link
EP (1) EP0514506B1 (no)
JP (1) JP2855594B2 (no)
AT (1) ATE137667T1 (no)
AU (1) AU645143B2 (no)
CA (1) CA2069760C (no)
DE (1) DE69119400T2 (no)
DK (1) DK0514506T3 (no)
ES (1) ES2088024T3 (no)
FI (1) FI107696B (no)
GR (1) GR3020674T3 (no)
IE (1) IE62194B1 (no)
NO (1) NO304729B1 (no)
PT (1) PT99113B (no)
SE (1) SE9003100D0 (no)
WO (1) WO1992005771A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260065A (en) * 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
KR100220546B1 (ko) * 1994-02-04 1999-09-15 벵 헤르슬로프 호지성 담체 제제
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
SE9703691D0 (sv) 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
EP1140021B1 (en) 1998-12-23 2004-08-04 Idea Ag Improved formulation for topical non-invasive application in vivo
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
FR2868704B1 (fr) * 2004-04-07 2007-09-14 Ethypharm Sa Utilisation de lipides pour ameliorer la biodisponibilite de principes actifs proteiques en formulations injectables sous cutanees ou intra-musculaires
MXPA06011871A (es) 2004-04-15 2007-10-08 Chiasma Inc Composiciones capaces de facilitar la penetracion a traves de una barrera biologica.
MX2007013421A (es) * 2005-04-28 2008-01-16 Galenica Technology Ab Formas de dosificacion farmaceutica que comprenden una fase lipida.
ATE544444T1 (de) * 2005-10-11 2012-02-15 Yissum Res Dev Co Zusammensetzungen für die nasale abgabe
WO2010032140A2 (en) 2008-09-17 2010-03-25 Chiasma Inc. Pharmaceutical compositions and related methods of delivery
CN101926757B (zh) 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
MA41462A (fr) 2015-02-03 2021-05-12 Chiasma Inc Méthode de traitement de maladies
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
AU2021444376A1 (en) * 2021-05-03 2023-11-16 Mcal Therapeutics Inc. Micronized lipids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT8219012A0 (it) * 1982-01-06 1982-01-06 Ausonia Farma Srl Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
JPH0753661B2 (ja) * 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
ATE115403T1 (de) * 1987-01-27 1994-12-15 Vestar Inc Aus phospholipiden bestehende darreichungsform für wasserunlösliche wirksubstanzen.

Also Published As

Publication number Publication date
PT99113B (pt) 1999-02-26
FI922452A0 (fi) 1992-05-27
ATE137667T1 (de) 1996-05-15
IE62194B1 (en) 1994-12-28
CA2069760A1 (en) 1992-03-29
AU8710591A (en) 1992-04-28
NO304729B1 (no) 1999-02-08
SE9003100D0 (sv) 1990-09-28
AU645143B2 (en) 1994-01-06
NO922084L (no) 1992-05-26
FI922452A (fi) 1992-05-27
WO1992005771A1 (en) 1992-04-16
EP0514506B1 (en) 1996-05-08
EP0514506A1 (en) 1992-11-25
PT99113A (pt) 1992-08-31
ES2088024T3 (es) 1996-08-01
DE69119400D1 (de) 1996-06-13
IE913246A1 (en) 1992-04-08
GR3020674T3 (en) 1996-10-31
JP2855594B2 (ja) 1999-02-10
DK0514506T3 (da) 1996-08-12
NO922084D0 (no) 1992-05-26
JPH05503711A (ja) 1993-06-17
DE69119400T2 (de) 1996-12-05
CA2069760C (en) 1998-02-10

Similar Documents

Publication Publication Date Title
FI107696B (fi) Lipidipartikkelinmuodostusmatriisi ja menetelmä sen valmistamiseksi
US5665379A (en) Lipid particle forming matrix, preparation and use thereof
Angelova et al. Liquid crystalline nanostructures as pegylated reservoirs of omega-3 polyunsaturated fatty acids: Structural insights toward delivery formulations against neurodegenerative disorders
Laouini et al. Preparation, characterization and applications of liposomes: state of the art
Hippalgaonkar et al. Injectable lipid emulsions—advancements, opportunities and challenges
Gupta et al. Biocompatible microemulsions and their prospective uses in drug delivery
Lawrence Microemulsions as drug delivery vehicles
US20020048596A1 (en) Preparation for the transport of an active substance across barriers
JP5142989B2 (ja) 脂質とスチレン及びマレイン酸の共重合体とを含む組成物
JP2002507966A (ja) 薬学的組成物の調製
EP2760433B1 (en) pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
CA2268670A1 (en) Preparation for transporting active ingredients through barriers
Ma et al. A highly stable norcantharidin loaded lipid microspheres: preparation, biodistribution and targeting evaluation
Ray et al. Noisomes: as novel vesicular drug delivery system
JPH07108166A (ja) リポソーム
Afreen et al. Pharmacosomes and emulsomes: an emerging novel vesicular drug delivery system
Mehta et al. Microemulsions: A potential novel drug delivery system
Cai et al. Lipid nanoparticle steric stabilization roadmap
Kasagi et al. Optimization of dihydrosphingomyelin/cholesterol mol ratio in topotecan-loaded liposomes to enhance drug retention and plasma half-life by understanding physicochemical and thermodynamic properties of the lipid membrane
AU2016700A (en) A pharmaceutical composition comprising cyclosporin in a lipid carrier
Patel et al. Niosome: a vesicular drug delivery tool
CN112190504B (zh) 一种含有玫瑰精油的长效液体凝胶及其制备方法和应用
Bhokare Transfersomes: a novel drug delivery system
Parmar et al. Conceptual aspects of vesicular drug delivery system with special reference to niosome
JPH10510207A (ja) 隔離剤

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA AB